Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction;A csontvelo eredetu CD34+ ossejtek hatása a bal kamra funkciójára akut miokardiális infarktust követoen

Orvosi Hetilap

Volumn 148, Issue 6, 2007, Pages 243-249

  Balogh, László ^a   Czuriga, István ^a   Hunyadi, János ^b   Galuska, László ^c   Kristóf, Éva ^a   Édes, István ^a,d  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Bor és Nemibeteggondozó Klinika   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d NONE   (Hungary)

Author keywords

Acute myocardial infarction; Heart failure; Stem cell therapy

Indexed keywords

CD34 ANTIGEN; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL FRACTIONATION; CELL HETEROGENEITY; CELL POPULATION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; MONONUCLEAR CELL; SAFETY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ADULT; BLOOD; BONE MARROW CELL; CLINICAL TRIAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART VENTRICLE REMODELING; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD34; BONE MARROW CELLS; ECHOCARDIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; STEM CELL TRANSPLANTATION; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34250160604     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.27994     Document Type: Article

References (15)

1. Strauer, B. E., Brehm, M., Gattermann, N. és mtsai: Myocardial regeneration after intracoronary transplantation of human autologous stem cells following acute myocardial infarction. Dtsch. med. Wschr., 2001, 126, 932-938.
2. Strauer, B. E., Brehm, M., Zeus, T. és mtsai: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 2002, 106, 1913-1918.
3. Strauer, B. E., Brehm, M., Zeus, T. és mtsai: Regeneration of human heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. The ICAT Study. J. Am. Coll. Cardiol., 2005, 46, 1651-1658.
4. Schächinger, V., Assmus, B., Britten, M. és mtsai: Transplantation of progenitor cells and regeneration enhancement in acut myocardial infarction. Final One-Year Result of TOCARE-AMI Trial. J. Am. Coll. Cardiol., 2004, 44, 1690-1699.
5. Meyer, G. P., Wollert, K. C., Lotz, J. és mtsai: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 2006, 113, 1287-1294.
6. Kuethe, F., Richartz, B. M., Sayer, H. G. és mtsai: Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarction. Int. J. Cardiol., 2004, 97(1), 123-127.
7. Schächinger, V., Tonn T., Dimmler, S. és mtsa: Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat. Clin. Pract., 2006, 3, S23-28.
8. Lunde, K., Solheim, S., Aakhus, S. és mtsai: Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspect. Scand. Cardiovasc. J., 2005, 39, 150-158.
9. Janssens, S., Dubois, C., Theunissen, K. és mtsai: Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomized trial. Lancet, 2006, 367, 113-121.
10. Katritis, D. G., Sotiropoulou, P. A., Karvouni, E. és mtsai: Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarct human myocardium. Cath. Cardiovasc Interv., 2005, 65, 321-329.
11. Erbs, S., Linke, A., Adams, V. és mtsai: Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: First randomized and placebo-controlled study. Circ. Res., 2005, 97, 756-762.
12. Peterson, E. D, Shaw, L. J, Califf, R. M.: Risk stratification after myocardial infarction. Ann. Intern. Med., 1997, 126, 561-582.
13. Packer, M. és mtsai: Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. Am. Heart J., 2001, 141, 899-907.
14. Kearney, M. T. és mtsai: Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J. Am. Coll. Cardiol., 2002, 40, 1801-1808.
15. Cintron, G. és mtsai: Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure: the V-HeFT VA Cooperative Studies Group. Circulation, 1993, 87(Suppl), 17-23.